Past glories and future potential for MediCity laboratories
MediCity, the health, beauty and wellness innovation hub, is opening over 3,000 sq ft of newly-refurbished world-class laboratory space to companies aspiring to create the next generation of healthcare and Over The Counter (OTC) products.
MediCity, the health, beauty and wellness innovation hub based in Nottingham, is opening over 3,000 sq ft of newly-refurbished world-class laboratory space to companies aspiring to create the next generation of healthcare and Over The Counter(OTC) products.
MediCity tenants can also hire technical equipment at BioCity Nottingham to the east of the city centre. This includes the Bruker 400 MHz NMR system, mass spectrometers, HP Liquid Chromatography system, Gas Chromatography system, centrifuges and freezers.
MediCity is a collaboration between Boots, the UK's leading pharmacy-led health and beauty retailer, and BioCity, the UK's leading life sciences incubation company. Nottingham Trent University is a member of BioCity Nottingham, was a founding leading partner in its creation and continues to play a strong role as a board member in relation to its development.
Situated within the Nottingham Enterprise Zone, the laboratories in MediCity, located in the historic D6 building on the Boots site, were once focussed on the development of well-known brands such as Strepsil. D6, previously also known as the 'Drys' factory, manufactured, stored and dispatched pills, tablets, pastilles, powders, toilet requisites and other dry products.
Interest in the new MediCity laboratories has already come from companies engaged in drug development, chewable vitamins and therapeutic cream applications.
Contract product development organisation, Co-Formulate Ltd occupies processing facilities along with office and laboratory space at MediCity. This enables Co-Formulate Ltd. to further expand its services in product development, analytical services and CMC regulatory affairs to support clients across the pharmaceutical, OTC healthcare, medical device and cosmetics industries. The highly-skilled team require the MediCity laboratory space for the growth in analytical services, small scale production and stability testing.
This move marks the return of Huw Jones, Director of Co-Formulate Ltd. to the laboratories he helped design in 1996 as an employee of the former Boots Healthcare International. Huw, said: "Since I left the company and founded Co-Formulate with fellow Director, Nazim Kanji, we have built a client base of leading pharmaceutical and consumer healthcare companies. We are ready to expand and MediCity is the ideal location for us. We can also tap into the MediCity business support and will be looking into the various financial schemes open to Nottingham life science companies."
David Browning, Director of MediCity, says: "Companies like Co-Formulate are looking for competitively-priced laboratories and offices so this is the ideal base to start and grow a venture, including those which might have very particular needs. Not only do they benefit from Enterprise Zone rate relief but also become part of a growing centre of excellence in health, beauty and wellness innovation."
Ged O'Shea, Director of Product Development at Boots, says: "We anticipate that MediCity will create opportunities for Boots UK to work with new partners and it is really encouraging to see the growth in interest in MediCity and the new tenants in the D6 building."
Notes for editors
BioCity and MediCity
Louise Third, Director, Integra Communications: +44 (0)115 912 4350/07773 288342
Clare Stafford / Bethan Simmons, Boots UK: +44 (0) 115 959 5995
MediCity is a collaboration between Boots, a member of Alliance Boots, and BioCity, the UK's leading life sciences incubation business. MediCity provides a stimulating and supportive business development environment for innovators in consumer healthcare, medical technology, diagnostics, and beauty products.
MediCity is based within the Nottingham Enterprise Zone on the Boots site in Beeston. Businesses housed at MediCity will benefit from BioCity's experience of growing successful businesses in specialised incubator environments and Alliance Boots expertise in the global healthcare market.
MediCity offers the ideal environment for both start-up and established companies to grow and achieve success. Businesses benefit from BioCity's proven track record in developing the right ecosystem for companies in the sector to thrive, and from the innovation and product development knowledge of Alliance Boots.
Hot desks and 'pods' provide the ideal working environment for individuals or small teams at the very early stages of developing a business idea. MediCity provides:
- laboratory and office facilities on a flexible basis
- access to high-end equipment
- shared services
- training, business support
- access to investment.
MediCity provides a venue for conferences and events of eventually up to 1,000 delegates focused on health, beauty and wellness. Support for the early stage businesses based at MediCity is part-funded by the European Regional Development Fund.
About Boots UK
Boots UK is the leading pharmacy-led health and beauty retailer in the UK, with close to 2,500 Boots UK stores and around 60,000 employees. Boots UK's purpose is to help customers look and feel better than they ever thought possible. Customers are at the heart of our business which is committed to providing exceptional customer and patient care, be the first choice for pharmacy and healthcare, offer innovative products 'only at Boots' such as the UK's leading skincare brand No7, all delivered with the great value our customers' love. Created over 160 years ago, the Boots brand is still at the heart of the communities it serves.
Boots UK is a member of Alliance Boots, a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Working in close partnership with manufacturers and pharmacists, Alliance Boots is committed to improving health in the local communities it serves and helping its customers and patients to look and feel their best. Its focus is on growing its two core businesses: pharmacy-led health and beauty retailing and pharmaceutical wholesaling and distribution. Alliance Boots has a presence in more than 25* countries and employs over 108,000* people. Alliance Boots has pharmacy-led health and beauty retail businesses in nine* countries and operates more than 3,100* health and beauty retail stores, of which just over 3,000* have a pharmacy.
*Figures are approximate as at 31 March 2013 and include associates and joint ventures.
About the Nottingham Enterprise Zone
In March 2011, the Alliance Boots site in Beeston, Nottingham, was awarded Enterprise Zone status by the UK Government. Enterprise Zones are designated areas with incentives to encourage the creation of new businesses, which will contribute to the growth of local and national economies.
The Nottingham Enterprise Zone is comprised of part of the Alliance Boots site in Beeston and three other smaller sites – the Beeston Business Park, the Nottingham Science Park and the MediPark site (at Queens Medical Centre) which together make up 286 acres (116 hectares).
The Alliance Boots site in total consists of 279 acres (113 hectares) and the Group’s vision is to create a UK centre for innovation in health beauty and wellness in Nottingham. The site will offer a cost effective, high quality, centrally located site for health and wellness businesses such as business incubators, start-ups and small and medium enterprises. As well as existing buildings suitable for redevelopment, the site also includes around 100 acres (40 hectares) of brownfield land suitable for development.
BioCity specialises in the creation and development of business incubation sites for the life sciences. It provides a home for new and growing businesses and creates the right environment for tenant companies to have the strongest chance of success.
BioCity does this by providing laboratory and office facilities on a flexible basis and access to high-end equipment, shared services, training, business support and access to investment.
In 2012, BioCity established BioCity Scotland, nr Glasgow and in 2013 BioHub at Alderley Park nr Manchester for Astra Zeneca providing 350,000 sq ft of quality lab and office facilities.
Over 100 companies started life in a BioCity business incubator and have raised £45m of seed capital. This growth formula has helped make BioCity an international hub for entrepreneurial activity in the life sciences.
About the European Regional Development Fund (ERDF) in the East Midlands
MediCity is part financed by the Structural Funds for the East Midlands Region of the European Regional Development Fund [ERDF] Programme 2007 to 2013. The Department for Communities and Local Government is the managing authority for the European Regional Development Fund Programme, which is one of the funds established by the European Commission to help local areas stimulate their economic development by investing in projects which will support local businesses and create jobs. For more information visit gov.uk.
Past glories and future potential for MediCity laboratories
- Category: Business; Research; School of Science and Technology